These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17570186)

  • 1. [Bone density and hypertension].
    Reyes Balaguer J
    Med Clin (Barc); 2007 Jun; 129(1):36; author reply 36. PubMed ID: 17570186
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone mineral content and blood pressure: What is the pathophysiologic link?
    Titze J
    Am J Hypertens; 2006 Aug; 19(8):877-8. PubMed ID: 16876694
    [No Abstract]   [Full Text] [Related]  

  • 3. BMI, hypertension and low bone mineral density in adult men and women.
    Szklarska A; Lipowicz A
    Homo; 2012 Aug; 63(4):282-91. PubMed ID: 22858154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of moexipril in postmenopausal women with hypertension and associated changes of bone mineral density].
    Kirichenko AA; Demel'khanova TS; Riazantsev AA; Novichkova IuN; Ebzeeva EIu; Iurchenko KV
    Kardiologiia; 2005; 45(7):34-7. PubMed ID: 16091658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between bone mineral density and arterial stiffness in hypertensive patients.
    Masugata H; Senda S; Inukai M; Murao K; Hosomi N; Iwado Y; Noma T; Kohno M; Miyatake N; Himoto T; Goda F
    Tohoku J Exp Med; 2011 Feb; 223(2):85-90. PubMed ID: 21263208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mass and body composition in children and adolescents with primary hypertension: preliminary data.
    Pludowski P; Litwin M; Sladowska J; Antoniewicz J; Niemirska A; Wierzbicka A; Lorenc RS
    Hypertension; 2008 Jan; 51(1):77-83. PubMed ID: 17984369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced bone mineral density in hypertensive patients is associated with left ventricular diastolic dysfunction, not left ventricular hypertrophy.
    Masugata H; Senda S; Murao K; Inukai M; Hosomi N; Iwado Y; Noma T; Kohno M; Miyatake N; Himoto T; Goda F
    Clin Exp Hypertens; 2012; 34(3):176-81. PubMed ID: 21966979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone loss at subchondral plate in knee osteoarthritis patients with hypertension and type 2 diabetes mellitus.
    Wen CY; Chen Y; Tang HL; Yan CH; Lu WW; Chiu KY
    Osteoarthritis Cartilage; 2013 Nov; 21(11):1716-23. PubMed ID: 23831668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of nitrendipine and hydrochlorothiazide on calciotropic hormones and bone density in hypertensive patients.
    Giles TD; Sander GE; Roffidal LE; Quiroz AC; Mazzu AL
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):875-9. PubMed ID: 1285936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory mechanisms underlying decreased bone mineral density in women with essential hypertension.
    Tsuda K
    Am J Hypertens; 2003 Oct; 16(10):893. PubMed ID: 14553974
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium, hypertension and loss of Bone mineral density in women.
    Kisters K; Kosch M; Rahn KH; Hausberg M
    Am J Hypertens; 2002 May; 15(5):475; author reply 475-6. PubMed ID: 12022253
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Amlodipine on Bone Metabolism in Orchidectomised Spontaneously Hypertensive Rats.
    Zivna H; Gradošová I; Zivny P; Cermakova E; Palicka V
    Pharmacology; 2018; 102(1-2):67-73. PubMed ID: 29898457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Contribution of Osteoprogenitor Cells to Arterial Stiffness and Hypertension.
    Pikilidou M; Yavropoulou M; Antoniou M; Yovos J
    J Vasc Res; 2015; 52(1):32-40. PubMed ID: 25925498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular calcification and subcortical bone demineralization in hypertension.
    Cirillo C; Bilancio G; Natale F; Concilio C; Russo MG; Calabrò P; Cirillo M
    Hypertens Res; 2017 Sep; 40(9):825-830. PubMed ID: 28381870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Primary Hypertension on Treatment Outcomes of Patients with Postmenopausal Osteoporosis: A 5 Year Follow Up Retrospective Study.
    Yilmaz V; Umay E; Gundogdu I; Cakcı FA
    High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):61-67. PubMed ID: 30467637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density in women with essential hypertension.
    Tsuda K; Nishio I; Masuyama Y
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):704-7. PubMed ID: 11465657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of voluntary weight loss on bone mineral density in older overweight women.
    Chao D; Espeland MA; Farmer D; Register TC; Lenchik L; Applegate WB; Ettinger WH
    J Am Geriatr Soc; 2000 Jul; 48(7):753-9. PubMed ID: 10894313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin and bone mass in postmenopausal hypertensive women.
    Pérez-Castrillón JL; Justo I; Sanz A; San Miguel A; Mazón MA; Abad L; Vega G; Dueñas A
    Ann Nutr Metab; 2007; 51(3):223-7. PubMed ID: 17587793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study.
    Hanley DA; Brown JP; Tenenhouse A; Olszynski WP; Ioannidis G; Berger C; Prior JC; Pickard L; Murray TM; Anastassiades T; Kirkland S; Joyce C; Joseph L; Papaioannou A; Jackson SA; Poliquin S; Adachi JD;
    J Bone Miner Res; 2003 Apr; 18(4):784-90. PubMed ID: 12674340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitamin D, vitamin D receptor and clinical disease].
    Xiang W; Ding ZY; Zheng W
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):541-4. PubMed ID: 15324579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.